Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round …
ERP solution will help Czech m…
Simultaneously supported by iQ…
ROCKVILLE, Md. and SUZHOU, Chi…
MELBOURNE, Australia, Nov. 28,…
SINGAPORE, Nov. 28, 2024 /PRNe…
Strategic Partnership to Stren…